Moreover, the expression of the miR-31 target genes SATB2 and RHOA was significantly reduced in SUM-159 cells after combination treatment with GBK and DDP, indicating that GBK could impair breast cancer cell migration and invasion. The gene discussed is RHOA; the disease is breast carcinoma.